PHARMALA BIOTECH
PharmAla Biotech is a biotechnology company that provides manufacturing and sales of MDMA substances to the clinical research community.
PHARMALA BIOTECH
Industry:
Biotechnology Health Care Manufacturing Pharmaceutical
Address:
Toronto, Ontario, Canada
Country:
Canada
Website Url:
http://www.pharmala.ca
Total Employee:
1+
Status:
Active
Contact:
+1 855 444 6362
Email Addresses:
[email protected]
Official Site Inspections
http://www.pharmala.ca Semrush global rank: 9.39 M Semrush visits lastest month: 165
- Host name: 104.248.104.88
- IP address: 104.248.104.88
- Location: Toronto Canada
- Latitude: 43.6547
- Longitude: -79.3623
- Timezone: America/Toronto
- Postal: M5A
More informations about "PharmAla Biotech"
PharmAla Biotech | Affiliations
Contact Us: PharmAla Biotech 1-855-444-MDMA (6362) 1 Adelaide St. E, Suite 801, Toronto, Ontario M5C 2V9 [email protected]See details»
PharmAla Biotech | Our Team - English
Before joining PharmAla, Harpreet was the Director of research and development for one of the world’s largest medical cannabis companies. During this time, she nurtured her exceptional …See details»
PharmAla to supply Harvard Medical School's Maclean Hospital …
Oct 2, 2024 PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with …See details»
PharmAla Biotech - Crunchbase Company Profile
Contact Email [email protected]; Phone Number +1 855 444 6362; PharmAla Biotech is a Canadian biotechnology company that specialises in the research, development, manufacturing, and sales of MDMA substances for …See details»
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA - Yahoo …
PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with regulators ...See details»
PharmAla to supply Mt. Sinai Hospital with LaNeo MDMA
Oct 21, 2024 PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with …See details»
PharmAla Biotech | PharmAla Launches Prescriber’s Portal ... - English
PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with regulators. Our …See details»
PharmAla Biotech ready to assist Alberta Government with
Oct 6, 2022 For more information, please visit www.PharmAla.ca, where you can sign up to receive regular new updates. ... Organization Profile. PharmAla Biotech Inc. Contact Cision. …See details»
PharmAla Biotech and Shaman Pharma Granted First Ever
May 16, 2023 PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with …See details»
PharmAla granted a Controlled Drugs & Substances Dealer's …
Jan 25, 2024 PharmAla’s research and development unit has completed proof-of-concept research into several IP families, including ALA-002, its lead drug candidate. PharmAla is a …See details»
PharmAla Biotech First Publicly Traded Company to Produce
Aug 17, 2022 For more information, please visit www.PharmAla.ca, where you can sign up to receive regular new updates. ... Organization Profile. PharmAla Biotech Inc. Contact Cision. …See details»
PharmAla Biotech | PharmAla Biotech and Filament Health
PharmAla Biotech Holdings Inc. (CSE: MDMA) is a biotechnology company focused on the research, development, and manufacturing of MDXX class molecules, including MDMA. …See details»
PharmAla Announces Private Placement - GlobeNewswire
Dec 13, 2024 PharmAla is a “regulatory first” organization, formed under the principle that true success in the psychedelics industry will only be achieved through excellent relationships with …See details»
PharmAla Issues Audited Financial Statements, Completes …
TORONTO, Dec. 20, 2024 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC: MDXXF), a biotechnology company focused on the …See details»
PharmAla Biotech completes filing of Patent application for
Aug 29, 2022 For more information, please visit www.PharmAla.ca, where you can sign up to receive regular new updates. ... Organization Profile. PharmAla Biotech Inc. Contact Cision. …See details»
Pharmala Biotech Holdings Inc. | CSE - Canadian Securities Exchange
2022-0110 - New Listing - Pharmala Biotech Holdings Inc. (MDMA) le 10 janvier/January 2022. The common shares of Pharmala Biotech Holdings Inc. have been approved for listing on the …See details»
PharmAla Biotech | -Our Focus - English
PharmAla works with established, best-in-class laboratories across Canada to develop novel processes for the supply of LaNeo™ MDMA and other MDXX substances. We hold ourselves …See details»
Pharmala Biotech Holdings Inc. - Canadian Securities Exchange
Jan 11, 2022 pharmala.ca. Social. ... Pharmala also intends to undertake development of novel formulations of MDMA and the MDXX class of compounds, as well as developing novel drug …See details»
PharmAla Biotech | PharmAla granted a Controlled Drugs ... - English
VANCOUVER, BC - January 25, 2024 - PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the …See details»